Share this @internewscast.com
As we enter the colder months in Australia, COVID-19 is making headlines again, this time due to the emergence of a new variant: NB.1.8.1.
Last week, the World Health Organization (WHO) designated NB.1.8.1 as a “variant under monitoring”, owing to its growing global spread and some notable characteristics which could set it apart from earlier variants.

So, what do you need to know about this new variant?

The current COVID-19 situation

More than five years since COVID-19 was initially declared a pandemic, we’re still experiencing regular waves of infections.

It’s more difficult to track the occurrence of the virus nowadays, as fewer people are testing and reporting infections. But available data suggests in late May 2025, case numbers in Australia were ticking upwards.

Genomic sequencing has confirmed NB.1.8.1 is among the circulating strains in Australia, and is generally increasing. Of cases sequenced up to 6 May across Australia, NB.1.8.1 ranged from less than 10 per cent in South Australia to more than 40 per cent in Victoria.
Wastewater surveillance in Western Australia has determined NB.1.8.1 is now the dominant variant in wastewater samples collected in Perth.
Internationally, NB.1.8.1 is also growing. By late April 2025, it comprised roughly 10.7 per cent of all submitted sequences — up from just 2.5 per cent four weeks before. While the absolute number of cases sequenced was still modest, this consistent upward trend has prompted closer monitoring by international public health agencies.

NB.1.8.1 has been spreading particularly in Asia — it was the dominant variant in Hong Kong and China at the end of April.

Where does this variant come from?

According to the WHO, NB.1.8.1 was first detected in samples collected in January 2025.

It’s a sublineage of the Omicron variant, descending from the recombinant XDV lineage. “Recombinant” is where a new variant arises from the genetic mixing of two or more existing variants.

What does the research say?

Like its predecessors, NB.1.8.1 carries a suite of mutations in the spike protein. This is the protein on the surface of the virus that allows it to infect us, specifically via the ACE2 receptors, a “doorway” to our cells.

The mutations include T22N, F59S, G184S, A435S, V445H, and T478I. It’s early days for this variant, so we don’t have much data on what these changes mean yet. But a recent preprint (a study that has not yet been peer-reviewed) offers some clues about why NB.1.8.1 may be gathering traction.

Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested — suggesting it may infect cells more efficiently than earlier strains.
The study also looked at how well antibodies from vaccinated or previously infected people could neutralise or “block” the variant. Results showed the neutralising response of antibodies was around 1.5 times lower against NB.1.8.1 compared to another recent variant, LP.8.1.1.

This means it’s possible a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants.

What are the symptoms?

The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. These factors could explain its rise in sequencing data.
But importantly, the WHO has not yet observed any evidence it causes more severe disease compared to other variants.
Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants.

Common symptoms include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases.

How about the vaccine?

There’s potential for this variant to play a significant role in Australia’s winter respiratory season. Public health responses remain focused on close monitoring, continued genomic sequencing, and promoting the uptake of updated COVID-19 boosters.
Even if neutralising antibody levels are modestly reduced against NB.1.8.1, the WHO has noted COVID-19 vaccines should still protect against severe disease with this variant.
The most recent booster available in Australia and many other countries targets JN.1, from which NB.1.8.1 is descended. So it makes sense that it should still offer good protection.
Ahead of winter and with a new variant on the scene, now may be a good time to consider another COVID-19 booster if you’re eligible. For some people, particularly those who are medically vulnerable, COVID-19 can still be a serious disease.
The Conversation Lara Herrero receives funding from the National Health and Medical Research Council.

Share this @internewscast.com
You May Also Like

Sarah Gigante of Australia Returns Triumphantly to Giro d’Italia After Surgery

Sarah Gigante has completed her dazzling maiden Giro d’Italia by finishing third…
A Play to Learn centre in Castle Hill went up in flames early Monday morning.

Another Childcare Center Catches Fire Shortly After First Suspicious Blaze

A second childcare centre in Sydney has gone up in flames just…
Assassins who killed Ukraine intelligence officer 'eliminated'

Ukrainian Intelligence Officer’s Killers Have Been ‘Neutralized’

Ukraine’s Security Service has announced the elimination of Russian special service agents…
Kalyn Ponga could be set to leave the Newcastle Knights at the end of the 2025 NRL season

Stunning Update on Kalyn Ponga’s Rugby League Career

Kalyn Ponga is reportedly contemplating a move away from the Newcastle Knights…
Dead birds found in Springvale, Melbourne

A Large Number of Bird Carcasses Discovered Near Melbourne Mall

The RSCPA is conducting an investigation into an alleged mass bird poisoning…
The mangled car remained on scene in Roxburgh Park while detectives investigated.

Police investigate weapon after car crash victim discovered with gunshot wound

Police are searching parklands for a weapon after a man was found…

Commemorating 30 Years Since the Srebrenica Genocide

Rukija Avdić cries as she recalls the night 30 years ago when…
A Chinese pipeline worth $120 billion at stake in crucial talks

Crucial Negotiations Put $120 Billion Chinese Pipeline Investment on the Line

Australia’s iron ore exports to China are a focal point today as…
Ben Te'o has the unique distinction of playing for the Lions and in a State of Origin

Ben Te’o: How Rugby Union and League Can Successfully Merge

Ben Te’o stands out for having achieved the rare feat of participating…

Hannah Thomas’ attorney claims police assaulted her and legal action may be pursued.

Lawyers for a former Greens candidate who suffered a serious eye injury…
Bus driver allegedly stabbed in Caloundra

Urgent Appeal for Action Following Passenger’s Stabbing of Bus Driver in the Throat

Warning: This story contains graphic content. A bus driver is recovering from…

Exploring the Roots and Impact: Is Everyone Capable of Hatred?

In the debut of our series, Understanding Hate, we delve into the…